SELECT FROM MENU

Therapy Area
Drug Classes

       Disease Area

All Sessions

All Sessions

All Sessions

Resectable NSCLC

All Sessions

Metastatic NSCLC

All Sessions

SCLC

All Sessions

Biomarkers

       Drug Class

Targeted Therapies

Targeted Therapies

Immuno-therapies

Immuno-therapies

Antibody-Drug Conjugates

Antibody-Drug Conjugates

Jair Bar

Jair Bar

Sheba Medical Center, Ramat Gan

Prof. Jair Bar is Head of the Thoracic Oncology Unit and Deputy Director of the Cancer Center at Sheba Medical Center in Ramat Gan, Israel, and a Professor of Oncology at Tel Aviv University. His research centers on lung cancer, immunotherapy resistance, and translational oncology, including precision-medicine and biomarker-driven treatment. He chairs the Israel Lung Cancer Group and serves as Chair of the Academy of the International Association for the Study of Lung Cancer (IASLC), reflecting his leadership in international thoracic oncology. He is a frequent speaker at major international thoracic oncology congresses.

Connect

Jair Bar

Featured in

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates